Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R McLaren

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The New Zealand Medical Journal|April 12, 1996
Breast cancer follow up; how much is enough?B R McLaren, C J Wynne
The New Zealand Medical Journal|September 22, 1993
Haemophilus parainfluenzae endocarditisB R McLaren, J G Turner
Internal Medicine Journal|February 14, 2013
Triple negative breast cancer in a male-to-female transsexualS T Pattison, B R McLaren
Cancer Chemotherapy and Pharmacology|June 15, 2000
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 productionB R McLaren, B W Robinson, R A Lake
Cancer Chemotherapy and Pharmacology|August 8, 2001
Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesotheliomaB R McLaren, D Whitaker, B W Robinson, et al.
Australian and New Zealand Journal of Medicine|September 14, 2000
Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomasB R McLaren, T Haenel, S Stevenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2013
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox IIV J Harvey, K J Sharples, R J Isaacs, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The New Zealand Medical Journal|April 12, 1996
Breast cancer follow up; how much is enough?B R McLaren, C J Wynne
The New Zealand Medical Journal|September 22, 1993
Haemophilus parainfluenzae endocarditisB R McLaren, J G Turner
Internal Medicine Journal|February 14, 2013
Triple negative breast cancer in a male-to-female transsexualS T Pattison, B R McLaren
Cancer Chemotherapy and Pharmacology|June 15, 2000
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 productionB R McLaren, B W Robinson, R A Lake
Cancer Chemotherapy and Pharmacology|August 8, 2001
Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesotheliomaB R McLaren, D Whitaker, B W Robinson, et al.
Australian and New Zealand Journal of Medicine|September 14, 2000
Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomasB R McLaren, T Haenel, S Stevenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2013
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox IIV J Harvey, K J Sharples, R J Isaacs, et al.
Pageof 1